BOLDRINI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 7.792
AS - Asia 3.584
EU - Europa 2.416
SA - Sud America 601
AF - Africa 177
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 14.579
Nazione #
US - Stati Uniti d'America 7.598
SG - Singapore 1.182
CN - Cina 1.120
IT - Italia 651
HK - Hong Kong 559
BR - Brasile 539
SE - Svezia 449
DE - Germania 332
BG - Bulgaria 253
VN - Vietnam 184
GB - Regno Unito 170
TR - Turchia 168
CA - Canada 159
FI - Finlandia 124
RU - Federazione Russa 110
KR - Corea 99
UA - Ucraina 82
CI - Costa d'Avorio 68
IN - India 65
FR - Francia 54
AT - Austria 53
SN - Senegal 36
BD - Bangladesh 33
CH - Svizzera 29
IQ - Iraq 28
JP - Giappone 27
AR - Argentina 22
BE - Belgio 21
MX - Messico 20
NL - Olanda 20
PL - Polonia 19
ZA - Sudafrica 18
UZ - Uzbekistan 17
ID - Indonesia 14
NG - Nigeria 13
ES - Italia 12
PK - Pakistan 12
IE - Irlanda 9
JO - Giordania 9
MA - Marocco 9
SA - Arabia Saudita 9
VE - Venezuela 9
AU - Australia 8
CO - Colombia 8
EG - Egitto 8
LT - Lituania 6
AZ - Azerbaigian 5
EC - Ecuador 5
IL - Israele 5
KZ - Kazakistan 5
PY - Paraguay 5
TN - Tunisia 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
CZ - Repubblica Ceca 4
KE - Kenya 4
LB - Libano 4
NP - Nepal 4
PH - Filippine 4
DZ - Algeria 3
GY - Guiana 3
HU - Ungheria 3
NI - Nicaragua 3
OM - Oman 3
PS - Palestinian Territory 3
RO - Romania 3
ZW - Zimbabwe 3
AL - Albania 2
BB - Barbados 2
BH - Bahrain 2
BJ - Benin 2
BN - Brunei Darussalam 2
CG - Congo 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GE - Georgia 2
IR - Iran 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
MD - Moldavia 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
BS - Bahamas 1
BW - Botswana 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GD - Grenada 1
GR - Grecia 1
KG - Kirghizistan 1
MM - Myanmar 1
MN - Mongolia 1
MY - Malesia 1
NA - Namibia 1
Totale 14.572
Città #
Ashburn 888
Fairfield 734
Singapore 625
Woodbridge 587
Chandler 574
Hong Kong 553
Dallas 525
Santa Clara 501
Ann Arbor 466
Houston 433
Seattle 298
Sofia 253
Beijing 252
Cambridge 248
Wilmington 248
Shanghai 230
New York 188
Boardman 126
Ottawa 126
Princeton 111
Hefei 109
Izmir 106
Jacksonville 105
Pisa 105
Lawrence 101
Medford 95
Milan 93
Seoul 93
Los Angeles 91
Nanjing 91
Serra 88
Des Moines 70
Florence 69
Abidjan 68
São Paulo 56
Istanbul 45
Frankfurt am Main 44
Munich 43
The Dalles 42
Columbus 41
Buffalo 40
Vienna 39
Dakar 36
Dong Ket 36
San Diego 36
Boulder 35
Dearborn 33
Redondo Beach 33
Council Bluffs 32
Nanchang 32
Ogden 29
Bremen 28
San Jose 28
Kunming 27
Chicago 25
Bern 24
London 23
Tokyo 23
Falls Church 22
Shenyang 22
Lancaster 21
Hanoi 20
Turku 20
Brussels 19
Hebei 19
Guangzhou 18
Ho Chi Minh City 17
Jüchen 17
Phoenix 17
Rio de Janeiro 17
Fuzhou 16
Redwood City 16
Rome 16
Tashkent 16
Baghdad 15
Warsaw 15
Changsha 14
Helsinki 14
Pune 14
Düsseldorf 13
Belo Horizonte 12
Cascina 12
Hangzhou 12
Toronto 12
Johannesburg 11
Lagos 11
Nuremberg 11
Nürnberg 11
Washington 11
Porto Alegre 10
Seacroft 10
Amman 9
Auburn Hills 9
Jiaxing 9
Jinan 9
Boston 8
Dhaka 8
Guarulhos 8
Norwalk 8
San Francisco 8
Totale 10.657
Nome #
Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell lines 233
Evaluation of telomerase in the development and progression of colon cancer. Int J Mol Med. 2002 Nov;10(5):589-92 202
Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance 201
EZH2 Expression in Intestinal Neuroendocrine Tumors 198
C-MYC, HIF-1α, ERG, TKT, and GSTP1: an Axis in Prostate Cancer? 196
EGFR and KRAS mutational analysis in a large series of Italian non-small cell lung cancer patients: 2,387 cases from a single center 192
Proposal for a New Diagnostic Histopathological Approach in the Evaluation of Ki-67 in GEP-NETs 185
Lung recurrence of papillary thyroid cancer diagnosed with antithyroglobulin antibodies after 10 years from initial treatment. 184
Let-7g and miR-21 expression in non-small cell lung cancer: correlation with clinicopathological and molecular features 182
Distinct Angiogenic microRNA-mRNA Expression Profiles Among Subtypes of Lung Adenocarcinoma. 182
Targeting of O6-methylguanine-DNA methyltransferase (MGMT) activity by antimessenger oligonucleotide sensitizes CHO/mex+ transfected cells to Mitozolomide 180
A high vascular count and overexpression of Vascular Endothelial Growth Factor (VEGF) are associated with unfavorable prognosis in operated Small Cell Carcinoma (SCLC) 177
Analysis of Fusion Genes by NanoString System: A Role in Lung Cytology? 177
Mutations of Fas (APO-1/CD95) and p53 genes in nonmelanoma skin cancer 176
Angiogenesis in intracranial meningiomas: immunohistochemical and molecular study 171
3T3 NIH murine fibroblasts and B78 murine melanoma cells expressing the "E. coli" N3-methyladenine-DNA glycosylase I do not become resistant to alkylating agents" 170
Alterations of Fas (APO-1/CD95) gene and its relationship with p53 in non small cell lung cancer 170
Neoangiogenesis and p53 protein in lung cancer: Their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression 169
CD34 microvessel density and VEGF expression in basal and squamous cell carcinoma 169
Effect of type I interferon(s) on cell viability and apoptosis in primary human thyrocyte cultures. 166
Differential microRNA expression profiles between young and old lung adenocarcinoma patients. 163
Anaplastic lymphoma kinase gene rearrangements in cytological samples of non-small cell lung cancer: comparison with histological assessment. 162
Neoangiogenesis as prognostic indicator of survival in lung cancer. 161
P2X7 protein expression and polymorphism in non-small cell lung cancer (NSCLC). 160
Identification of Fas (APO-1/CD95) and p53 gene mutations in non-small cell lung cancer 158
Evaluation of telomerase in non-melanoma skin cancer 157
Management of peritoneal carcinomatosis with cytoreductive surgery combined with intraperitoneal chemohyperthermia at a novel italian center 157
Inherited germline T790M mutation and somatic epidermal growth factor receptor mutations in non-small cell lung cancer patients 154
Intraoperative sentinel lymph node mapping in stage I non-small cell lung cancer: detection of micrometastases by polymerase chain reaction 151
Immunohistochemical and molecular study of radiation-induced multiple meningiomas with pleural and pulmonary metastasis 150
Expression Profiling of LKB1 Pathway in Young and Old Lung Adenocarcinoma Patients. 150
Interleukin-8 in non-small cell lung carcinoma: relation with angiogenic pattern and p53 alterations 150
Quantitation of in vitro activity of synthetic trans-acting ribozyme using HPLC 149
VALUTAZIONE DELL'ATTIVITA' TELOMERASICA E DELL'ESPRESSIONE DI hTERT mRNA IN ADENOCARCINOMA DEL COLON 149
Primary small cell carcinoma of the ureter: Case report and review of the literature 149
A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinoma 145
COINVOLGIMENTO DEL SISTEMA FAS(CD95/APO-1)/FAS LIGANDO NEL PROCESSO DI APOPTOSI p53-MEDIATO IN ADENOCARCINOMI DEL COLON 144
Effect of Interferon-α and β on FAS mediated apoptosis and IL-6 release in Human primary thyrocytes 144
The genotoxicity of the chlroethylating agent Mitozolomide is enhanced in CHO MEX+ cells by the administration of antimessenger oligonucleotide targeted against Methylguanine-DNA methyltransferase gene (MGMT) 143
Expression and function of P2X7 receptor in papillary thyroid cancer: a new potential marker of the disease? 143
Expression profiling and microRNA regulation of the LKB1 pathway in young and aged lung adenocarcinoma patients 143
Regulation of telomerase and its hTERT messenger in colorectal cancer 139
null 138
Evaluation of telomerase mRNA (hTERT) in colon cancer 133
Alterazioni del gene Fas (APO-1/CD95) nei carcinomi polmonari non a piccole cellule (NSCLC). Correlazioni con le alterazioni del gene P53. 132
Intraoperative sentinel lymph node mapping in stage I non-small cell lung cancer: detection of micrometastases by polymerase chain reaction 131
Intraductal prostate cancer: An aggressive subset of prostate cancers? Immunophenotypic evaluation 131
Delta N133p53 Expression Levels in Relation to Haplotypes of the TP53 Internal Promoter Region 130
null 130
Osteopontin expression and prognostic significance in non-small cell lung cancer 129
Expression of p-AKT and p-mTOR in a large series of bronchopulmonary neuroendocrine tumors 128
Gastrin-Releasing Peptide Receptor in Low Grade Prostate Cancer: Can It Be a Better Predictor Than Prostate-Specific Membrane Antigen? 128
Alterations of Fas (APO-1/CD95) gene and its relationship with p53 in non small cell lung cancer 127
The administration of gefitinib in patients with advanced non-small-cell lung cancer after the failure of erlotinib 126
Differential microRNA Expression Profile between Young and Old Lung Adenocarcinoma Patients. 126
Role of microRNA-33a in regulating the expression of PD-1 in lung adenocarcinoma. 124
The role of somatostatin in vasogenic meningioma associated brain edema 123
Neoangiogenesis in colon cancer: Correlation between vascular density, vascular endothelial growth factor (VEGF) and p53 protein expression 123
Meningioma-associated brain oedema: the role of angiogenic factors and pial blood supply 122
Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance 121
p16 and its putative interplay with metabolic factors in prostate cancer: An analysis based on public TCGA data 121
Vascular endothelial growth factor is associated with neovascularization and influences progression in Non Small Cell Lung Carcinoma (NSCLC). Clin Cancer Research 3: 861-865, 1997 120
Telomerase in intracranial meningiomas 120
Quantitation by competitive PCR assay of vascular endothelial growth factor (VEGF) in non-small cell lung carcinomas 119
Unusual Case of Pancreatic Adenocarcinoma with Bladder Metastasis 117
null 116
Thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer and normal mucosa in patients 115
Tumor necrosis factor/a and trasforming growth/b are significantly associated with better prognosisi in non small cell lung carcinoma: putative relation with bcl-32-mediated neovascularization 115
NEOANGIOGENESI IN ADENOCARCINOMI DEL COLON 112
WSB1 Involvement in Prostate Cancer Progression 111
null 111
Are Renal Cell Carcinoma with Fibromyomatous Stroma (RCC-FMS) and Thyroid-like Follicular Carcinoma of the Kidney (TLFCK) Really Independent Variants? 110
Expression of vascular endothelial growth factor mRNA in non-small-cell lung carcinomas 109
Multi-dimensional scaling analysis of key regulatory genes in prostate cancer using the tcga database 109
Modulation of neoangiogenesis in bronchial preneoplastic lesions 107
Vascular endothelial growth factor is associated with neovascularization and influences progression in Non Small Cell lung Carcinoma (NSCLC) 103
Bel2 and p53 regulate vascular endothelial growth factor(VEGF)-mediated angiogenesis in non-small cell lung carcinoma. 102
Telomerase activity and hTERT mRNA expression in gliomas 102
Interferon Beta induces IL-6 release but not apoptosis in primary cultures of human thyrocytes 101
Mutational analysis in cytological specimens of advanced lung adenocarcinoma: A sensitive method for molecular diagnosis 101
TSP1 and TSP2 mRNA expression in lung carcinoma: relation with p53 alterations, angiogenic growth factors and vascular density 100
Prognostic role of TPL2 in early‑stage non‑small cell lung cancer 99
null 98
Expression of miRNA-25 in young and old lung adenocarcinoma 96
Polymorphisms within inflammatory genes and colorectal cancer 94
Response to erlotinib in a patient with lung adenocarcinoma harbouring the EML4-ALK translocation: A case report. 94
Steroid Hormones as Modulators of Emotional Regulation in Male Urogenital Cancers 92
Role of endothelin-1 in angiogenic phenomenon in intracranial meningiomas 91
Non-small-cell lung cancer in women: Clinical and molecular aspects 90
Epidermal growth factor receptor and K-RAS mutations in 411 lung adenocarcinoma: A population-based prospective study 89
Tumour necrosis factor-alpha and transforming growth factor-beta are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL-2-mediated neovascularization 87
Expression of cyclooxygenase-2 and its correlation with vasogenic brain edema in human intracranial meningiomas 86
null 83
Regulation of telomerase and its hTERT messenger in colorectal cancer 82
Expression of endothelia-1 is related to poor prognosis in non-small cell lung carcinoma Anno 2005 Titolo della Rivista Titolo EUROPEAN JOURNAL OF CANCER ISSN 0959-8049 82
PLLA/Gelatine Spongy Matrices for the Regeneration of Bone Tissue 81
Prognostic significance of osteopontin expression in early-stage non-small-cell lung cancer 81
Non-small-cell lung cancer in women: Clinical and molecular aspects 78
Expression of endothelin-1 (ET-1) and cyclooxygenase-2 (COX-2) in intracranial meningiomas 77
Thrombospondins I and II messenger RNA expression in lung carcinoma: Relationship with p53 alterations, angiogenic growth factors, and vascular density 74
Totale 13.278
Categoria #
all - tutte 42.808
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.808


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021430 0 0 0 0 0 0 40 64 80 45 47 154
2021/20221.260 10 83 55 75 272 190 39 74 50 36 46 330
2022/20231.554 171 173 112 166 166 221 5 125 292 5 111 7
2023/2024925 86 78 126 34 137 194 32 44 17 14 60 103
2024/20253.650 29 127 24 213 394 443 325 190 346 458 380 721
2025/20262.366 296 505 567 229 429 328 12 0 0 0 0 0
Totale 14.776